Hepion Pharmaceuticals Inc (HEPA)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 69.7M | 60.24M | 49.5M | 36.5M | 25M | 18.09M | 15.99M | 6.01M |
流動資産合計 | 65.67M | 56.5M | 45.81M | 32.76M | 21.27M | 17.49M | 15.43M | 5.48M |
現金および同等物 | 59.15M | 51.19M | 42.99M | 30.52M | 19.28M | 14.79M | 13.11M | 2.12M |
非流動資産合計 | 4.11M | 3.83M | 3.75M | 3.8M | 3.78M | 635k | 559k | 528k |
負債合計 | 10.44M | 10.39M | 12.34M | 10.13M | 8.84M | 10.81M | 8.47M | 2.45M |
流動負債合計 | 7.49M | 7.89M | 9.8M | 7.67M | 6.4M | 5.29M | 2.57M | 975k |
非流動負債合計 | 2.95M | 4.6M | 2.54M | 2.46M | 2.44M | 5.52M | 5.89M | 1.47M |
普通株 | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M |
留保所得 | -168.89M | -175.7M | -188.96M | -203.04M | -213.57M | -224.63M | -227.48M | -231.41M |
年末 2023年12月31日 | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 18.39M | 11.25M | 8.19M | 20.43M | 48.65M | 103.55M | 60.24M | 18.09M |
流動資産合計 | 13.19M | 6.06M | 2.97M | 14.39M | 42.64M | 97.45M | 56.5M | 17.49M |
現金および同等物 | 12.98M | 5.95M | 2.83M | 13.92M | 40.73M | 91.35M | 51.19M | 14.79M |
非流動資産合計 | 9.06M | 3.7M | 1.98M | 16.19M | 40.52M | 93M | 49.86M | 7.28M |
負債合計 | 9.33M | 7.55M | 6.21M | 4.25M | 8.13M | 10.56M | 10.39M | 10.81M |
流動負債合計 | 2.95M | 2.6M | 2.85M | 1.25M | 4.66M | 8.21M | 7.89M | 5.29M |
非流動負債合計 | 6.38M | 4.95M | 3.36M | 3M | 3.64M | 4.24M | 4.6M | 5.52M |
総資本 | 9.06M | 3.7M | 1.98M | 16.19M | 40.52M | 93M | 49.86M | 7.28M |
普通株 | 1.05M | 1.05M | 1.79M | 1.72M | 1.72M | 1.71M | 1.7M | 1.7M |
留保所得 | -59.5M | -67.02M | -76.46M | -83.19M | -104.11M | -133.5M | -175.7M | -224.63M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約